16_potopnyk

Ser. Khim. 2008. No 49. Part 2. P. 96–101 O (&)
Ph-NH-NH2
1) KOH, EtOH
8, X = S, Y = O;
9, X = O, Y = S
10, X = S, Y = O;
11, X = O, Y = S
10, 11 13,
18–21. +
R = COOEt (14,18); C(S)NH2 (15,19); CONHPh (16,20);
! 2-(* !+,( $
5+4 1H, ': 1,33 (3 H, CH3,.2, J = 6,8); 2,06 (3 ., CH3); 4,20 (2 ., ,.2), J = 6,8); 6,84 (1 H, Ph); 7,19–7,28 (4 H, Ph); 9,65 (1 H, , %: C 63,77; H 6,32; N 13,12. C11H14N2O2. ) ! 4-* (% !-1-* !-1H- ( $ !-3-
5+4 1H, ': 1,42 (3 H, CH3,.2, J = 7,2); 4,42 (2 H, CH2), J = 7,2); 7,40 (1 H, Ph, J = 7,6); 7,51 (2 H, Ph, J = 7,6); 7,98 (2 H, Ph, J = 7,6); 9,17 , %: C 63,27; H 4,84; N 11,02. C13H12N2O3. (% !-1-* !-1H- ( $ !-3-
5+4 1., ': 7,41 (1 ., Ph, J = 8,0); 7,53 (2 ., Ph, J = 8,0); 8,00 (2 ., Ph, J = 8,0); 9,14 (1 ., $ ! 4-[(1,3-R2-2,4,6- (
" ( +,( -5(2H)-
% !]-1-* !-1 - ( $ !-3-
& (6, 7).
4-[(2,4,6- (
" ( +,( -5(2H)-
! , )% !]-1-* !-
1 - ( $!-3- (# " ! (6).
(2 H, CH2)); 7,48 (1 H, Ph); 7,60 (2 H, Ph); 7,85 (2 H, Ph); 8,96 (1 H, 9,67 (1 H, CH=); 11,31 (1 ., NH); 11,37 (1 ., NH). ! ! 4-[(1,3-, % !-2,4,6- (
" ( +,( -5(2H)-
!]-1-* !-1 - ( $ !-3-
(2), 0,32 (2,0
5+4 1H, ': 1,41 (3 H, CH3,.2); 3,12 (6 ., 2CH3N); 4,41 (2 H, CH2)); 7,49 (1 H, Ph); 7,60 (2 H, Ph); 7,83 (2 H, Ph); 9,01 (1 H, , %: C 58,91; H 4,55; N 14,32. C19H18N4O5. ) 4-[(4(2)- " -2(4)-
" -1,3-
$ ! , -5- ! , )% !]-1-* !-1 -
(10, 11). ,
4-[(4- " -2-
" -1,3-
$ ! , -5- ! , )% !]-1-* !-1 - ( -
(10). * . = 235 °,.
4-[(2- " -4-
" -1,3-
$ ! , -5- ! , )% !]-1-* !-1 - ( -
(11). * . = 238 °,.
CH3,.2); 4,34 (2 H, CH2)); 7,41 (1 H, Ph); 7,52 (2 H, Ph); 7,92 (2 H, Ph); 8,01 ! 4-[(3-% !-5-
" -1-* !-1,5-, +,( -4 - ( $ !-4- ! , )% !]-1-
* !-1 - ( $ !-3-
(2), 0,7 (4,1
, %: C 68,17; H 4,82; N 13,55. C23H20N4O3. ) 18–21.
1417 8
-3- " -3- " -1- ( !)-1-* !-1 - ( $!-3- (# -
(18). * . = 126128 °, (
CH3,.2); 1,43 (3 H, CH3,.2); 4,34 (2 H, CH2)); 4,41 (2 H, CH2)); 7,47 (1 H, Ph); 7,58 (2 H, Ph); 7,89 (2 H, Ph); 8,86 (1 H, CH=); 9,14 (1 H, -3- " -1- ( !)-1-* !-1 - ( $!-3- (# -
(19). * . = 188190 °, (
1,43 (3 H, CH3,.2, J = 7,2); 4,43 (2 H, CH2), J = 7,2); 7,11 (1 H, Ph, J = 7,6); 7,33 (2 H, Ph, J = 7,6); 7,47 (1 H, Ph, J = 7,6); 7,60 (2 H, Ph, J = 7,6); 7,70 (2 H, Ph, J = 7,6); 7,92 (2 H, Ph, J = 7,6); 8,75 (1 H, CH=); 9,15 (1 H, , %: C 67,21; H 4,63; N 14,05. C22H18N4O3. ) 4-(3- % -2--
" -1- ( !)-1-* !-1 - ( $ !-3-
(20). * . = 264265 °, ( +60).
(3 H, CH3,.2, J = 7,2); 4,41 (2 H, CH2), J = 7,2); 7,46 (1 H, Ph, J = 7,6); 7,59 (2 H, Ph, J = 7,6); 7,89 (2 H, Ph, J = 7,6); 8,70 (1 H, CH=); 9,16 (1 H, -2-(4-* !-1,3- $!-2- !) !]-1-* !-1 - ( $!-3- (-
(21). * . = 196 °, ( +60).
CH3,.2, J = 7,2); 4,45 (2 H, CH2), J = 7,2); 7,36 (1 ., Ph); 7,45 (3 ., Ph); 7,60 (2 ., Ph); 7,93 (2 ., Ph); 8,01 (2 ., Ph); 8,12 (1 ., , %: C 66,84; H 4,03; N 12,86, S 7,42. C24H18N4O2S. ) $ 2-* !-2,6-, +,( -7H- ( $ ! [3,4-d]
2, 18–21 7
5+4 1.: 7,47 (1 ., Ph, J = 7,6); 7,58 (2 H, Ph, J = 7,6); 8,03 (2 ., Ph, J = 7,6); 8,26 c 1. Bebernitz G.R., Argentieri G., Battle B., Brennan C., Balkan B., Burkey B.F. et al. The Effect of 1.3-Diaryl-[1H]-pyrazole-4-acetamides on Glucose Utilization in ob/ob Mice // J. Med. Chem. 2001. Vol. 44. N 16. P. 2601–2611. 2. Abadi A.H., Eissa A.A.H., Hassan G.S. Synthesis of novel 1,3,4-trisubstituted pyrazole derivatives and their evaluation as antitumor and antiangiogenic agents // Chem. Pharm. 3. Lange J.H.M., van Stuivenberg H.H., Coolen H.K.A.C., Adolfs T.J.P. et al. Bioisosteric replacements of the pyrazole moiety of rimonabant: synthesis, biological properties, and molecular modeling investigations of thiazoles, triazoles, and imidazoles as potent and selective CB1 cannabinoid receptor antagonists // J. Med. Chem. 2005. Vol. 48. N 6. 4. Mallegol T., Gmouh S., Meziane M.A.A., Blanchard-Desce M., Mongin O. Practical and Efficient Synthesis of Tris(4-formylphenyl)amine, a Key Building Block in Materials Chemistry // Synthesis. 2005. N 11. 4. 1771–1774. 5. Caluwe P. Heteroannelations with o-aminoaldehydes // Tetrahedron. 1980. Vol. 36. 6. Denison S., Hilton S.T. A Convenient Synthesis of 2-Cyano-3-Substituted Indoles // Synlett. 2004. N 15. P 2806–2808.07.12.204 7. Kira M.A., Abdel-Raemann M.O., Gadalla K.Z. The VilsmeierHaack reaction.
III. Cyclization of hydrazones to hyrazoles // Tetrahedron Lett. 1969. N 2. P. 109–110. 8. Kira M.A., Aboul-Enein N.M., Korkor K.Z. The VilsmeierHaack reaction. IV. Reaction
of Phosphorus Oxychloride-Dimethylformamide with Semicarbazones // J. Heterocycl. 9. Brehme R., Gründemann E., Schneider M. Reaktion von Acetophenonmono-methyl- und -dimethylhydrazonen mit dem VilsmeierReagenz; Bildung von Pyrazol-4-
carbiminiumsalzen: ein Beitrag zum Mechanismus // J. Prakt. Chem. 2000. Bd. 7. SYNTHESIS AND CHEMICALS CHARACTERISTICS OF ETHYL
4-FORMYL-1-PHENYL-1H-PYRAZOLE-3-CARBOXYLATE
M. Potopnyk, V. Matiychuk
Ivan Franko National University of Lviv, Kyryla & Mefodiya Str., 6, 79005 Lviv, Ukraine Ethyl 4-formyl-1-phenyl-1H-pyrazole-3-carboxylate was synthesized by reaction of ethyl 2-(phenylhydrazono)propanoate with the Vilsmeier–Haack complex. New methods of synthesis of 2-phenil-2,6-dihydro-7H-pyrazolo[3,4-d]pyridazin-7-one were suggested. Key words: pyrazoles, Vilsmeier–Haack reagent.

Source: http://chem.lnu.edu.ua/visnyk_2008/ORGAN/16_Potopnyk.pdf

Normal version 1.00

The British School, Al Rehab Location EG910 October / November 2013 CAMBRIDGE INTERNATIONAL EXAMINATIONS Pre IG/IGCSE / AS / A2 EXAMINATIONS – October/November INSTRUCTIONS TO CANDIDATES FROM EG910 PLEASE READ THE FOLLOWING INSTRUCTIONS VERY CAREFULLY Dear Candidate, You must be in possession of the following documents at all your examinations which yo

Renitec, inn-enalapril

RESUMO DAS CARACTERÍSTICAS DO MEDICAMENTO NOTA: ESTE RCM FOI O ANEXADO Á DECISÃO DA COMISSÃO, RELATIVA Á SUBMISSÃO PARA ARBITRAGEM; O TEXTO VÁLIDO NA ALTURA. O TEXTO NÃO É REVISTO OU ACTUALIZADO PELA EMEA E POR ISSO NÃO REPRESENTA NECESSARIAMENTE O TEXTO ACTUAL. 1. DENOMINAÇÃO MEDICAMENTO < Renitec e denominações associadas (ver Anexo I)>, <dosagem>,

Copyright ©2018 Drugstore Pdf Search